The DOI matches its Crossref record; 144 of the 145 references it cites were found in a registry or an index.
Glutaminolysis and autophagy in cancer
Open accessAbstract
The remarkable metabolic differences between cancer cells and normal cells result in the potential for targeted cancer therapy. The upregulation of glutaminolysis provides energetic advantages to cancer cells. The recently described link between glutaminolysis and autophagy, mediated by MTORC1, may constitute an attractive target for therapeutic strategies. A combination of therapies targeting simultane-ously cell signaling, cancer metabolism, and autophagy can solve therapy resistance and tumor relapse problems, commonly observed in patients treated with most of the current targeted therapies. In this review we summarize the mechanistic link between glutaminolysis and autophagy, and discuss the impacts of these processes on cancer progression and the potential for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, enhanced glutaminolysis might eventually contribute to the initiation and progression of cancer by stimulating cell growth via the mTORC1 pathway and enhancing aerobic glycolysis while disrupting the proper elimination of misfolded proteins, damaged DNA and organelles through the inhibition of autophagy and the DNA damage response166.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [166]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Csibi, A., Lee, G., Yoon, S.-O., Tong, H., Ilter, D., Elia, I., Fendt, S., Roberts, T. M., & Blenis, J. (2014) · Current Biology · doi:10.1016/j.cub.2014.08.007 · Cited by 253
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Research works printed but not linked: 3
- Kovacevic Z, 1972, Cancer Res, 32, 326
- Icard P, 2012, Biochim Biophys Acta, 1825, 111
- Catane R, 1979, Cancer Treat Rep, 63, 1033
Cited by
Sorted by citations
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
Molecular mechanisms of ferroptosis and its role in cancer therapy
Xu, T., Ding, W., Ji, X., Ao, X., Liu, Y., Yu, W., & Wang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14511 · Cited by 644
Autophagy in health and disease: A comprehensive review
Saha, S., Panigrahi, D. P., Patil, S., & Bhutia, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.007 · Cited by 522
Cancer-associated adipocytes: key players in breast cancer progression
Wu, Q., Li, B., Li, Z., Li, J., Sun, S., & Sun, S. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0778-6 · Cited by 462
Tafani, M., Sansone, L., Limana, F., Arcangeli, T., Santis, E. D., Polese, M., Fini, M., & Russo, M. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3907147 · Cited by 379
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Nong, S., Han, X., Yu, X., Qian, Y., Wei, Y., Zhang, T., Tian, K., Shen, K., Yang, J., & Ma, X. (2023) · MedComm · doi:10.1002/mco2.218 · Cited by 313
Phosphorylation of PDHA by AMPK Drives TCA Cycle to Promote Cancer Metastasis
Cai, Z., Li, C., Han, F., Liu, C., Zhang, A., Hsu, C.-C., Peng, D., Zhang, X., Jin, G., Rezaeian, A.-H., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.018 · Cited by 233
mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer
de la Cruz-López, K. G., Toledo-Guzmán, M. E., Sánchez, E. O., & Carrancá, A. G. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01373 · Cited by 223
Cytotoxic T-cells mediate exercise-induced reductions in tumor growth
Rundqvist, H., Veliça, P., Barbieri, L., Gameiro, P. A., Bargiela, D., Gojkovic, M., Mijwel, S., Reitzner, S. M., Wulliman, D., Ahlstedt, E., et al. (2020) · eLife · doi:10.7554/elife.59996 · Cited by 216
“, 2008) and aKG-mediated activation of mTORC1 has been reported in multiple cell lines (DeBerardinis et al., 2007; Durán et al., 2013; Villar et al., 2015), as well as in activated CD8 + T-cells (Suzuki et al.”
BackgroundGlutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation
Tan, H. W. S., Sim, A. Y. L., & Long, Y. C. (2017) · Nature Communications · doi:10.1038/s41467-017-00369-y · Cited by 205
S‐adenosylmethionine: A metabolite critical to the regulation of autophagy
Ouyang, Y., Wu, Q., Li, J., Sun, S., & Sun, S. (2020) · Cell Proliferation · doi:10.1111/cpr.12891 · Cited by 184
He, Q., Liu, M., Huang, W., Chen, X., Zhang, B., Zhang, T., Wang, Y., Liu, D., Xie, M., Ji, X., et al. (2021) · Hepatology · doi:10.1002/hep.32062 · Cited by 178
Zhang, Z., Liu, R., Shuai, Y., Huang, Y., Jin, R., Wang, X., & Luo, J. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0637-9 · Cited by 125
Song, X., Gong, Z., Liu, K., Kou, J., Liu, B., & Liu, K. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101559 · Cited by 113
Zhao, H., Dennery, P. A., & Yao, H. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00521.2017 · Cited by 116
Zhang, X., Li, Z., Xuan, Z., Xu, P., Wang, W., Chen, Z., Wang, S., Sun, G., Xu, J., & Xu, Z. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0993-y · Cited by 106
RetractedNon-apoptotic cell death in malignant tumor cells and natural compounds
Ye, J., Zhang, R., Wu, F., Zhai, L., Wang, K., Xiao, M., Xie, T., & Sui, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.061 · Cited by 103
The Mechanism of Ferroptosis and Applications in Tumor Treatment
Lin, X., Ping, J., Wen, Y., & Wu, Y. R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01061 · Cited by 107
Therapeutic implications of tumor interstitial acidification
Kolosenko, I., Avnet, S., Baldini, N., Viklund, J., & Milito, A. D. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.01.008 · Cited by 101
Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition
Han, S., Zhu, L., Zhu, Y., Meng, Y. G., Li, J., Song, P., Yousafzai, N. A., Feng, L., Chen, M., Wang, Y., et al. (2021) · Theranostics · doi:10.7150/thno.60028 · Cited by 95
Polyphenols as Promising Drugs against Main Breast Cancer Signatures
Losada-Echeberría, M., Herranz‐López, M., Micol, V., & Barrajón‐Catalán, E. (2017) · Antioxidants · doi:10.3390/antiox6040088 · Cited by 95
Villar, V. H., Nguyen, T.-L., Delcroix, V., Terés, S., Bouchecareilh, M., Salin, B., Bodineau, C., Vacher, P., Priault, M., Soubeyran, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms14124 · Cited by 90
Self-citationTwo parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis
Bodineau, C., Tomé, M., Courtois, S., Costa, A. S. H., Sciacovelli, M., Rousseau, B., Richard, É., Vacher, P., Parejo-Pérez, C., Bessède, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25079-4 · Cited by 84
Self-citationLiu, C., Li, Y., Wei, M., Zhao, L., Yu, Y., & Li, G. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1578146 · Cited by 82
Ye, J., Jiang, X., Dong, Z., Hu, S., & Xiao, M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s217944 · Cited by 79
Pham, D., & Park, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031444 · Cited by 73
Energy Metabolism Rewiring Precedes UVB-Induced Primary Skin Tumor Formation
Hosseini, M., Dousset, L., Mahfouf, W., Serrano-Sanchez, M., Redonnet‐Vernhet, I., Mesli, S., Kasraian, Z., Obre, É., Bonneu, M., Claverol, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.060 · Cited by 71
Hoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
Demas, D. M., Demo, S. D., Fallah, Y., Clarke, R. C., Nephew, K. P., Althouse, S. K., Sandusky, G. E., He, W., & Shajahan‐Haq, A. N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00686 · Cited by 71
Regulation of mTORC1 by amino acids in mammalian cells: A general picture of recent advances
Zhang, S., Lin, X., Hou, Q., Hu, Z., Wang, Y., & Wang, Z. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.05.003 · Cited by 68
The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling
Merhi, A., Delrée, P., & Marini, A. M. (2017) · Scientific Reports · doi:10.1038/srep44602 · Cited by 51
Du, Y., Miao, W., Jiang, X. W., Cao, J., Wang, B., Wang, Y., Yu, J., Wang, X., & Liu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.683951 · Cited by 50
Glutamine metabolism: from proliferating cells to cardiomyocytes
Shen, Y., Zhang, Y., Li, W., Chen, K., Xiang, M., & Ma, H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154778 · Cited by 44
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
Kumar, M. A., Baba, S. K., Khan, I. R., Khan, M. S., Husain, F. M., Ahmad, S., Haris, M., Singh, M., Akil, A. A., Macha, M. A., et al. (2025) · MedComm · doi:10.1002/mco2.70120 · Cited by 52
Ammonia and autophagy: An emerging relationship with implications for disorders with hyperammonemia
Soria, L. R., & Brunetti‐Pierri, N. (2019) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12061 · Cited by 43
Zhang, H., Lu, Y. P., Liang, Y., Jiang, L.-L., & Cai, Z. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.122475 · Cited by 43
The role of PKM2 in cancer progression and its structural and biological basis
Wu, B., Liang, Z., Lan, H., Teng, X., & Wang, C. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01007-0 · Cited by 43
The role of the glutamine transporter ASCT2 in antineoplastic therapy
Teixeira, E., Silva, C., & Martel, F. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04218-6 · Cited by 42
Nguyen, T.-L., Nokin, M., Terés, S., Tomé, M., Bodineau, C., Galmar, O., Pasquet, J., Rousseau, B., van Liempd, S., Falcón‐Pérez, J. M., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12877 · Cited by 41
Self-citationFarris, J. C., Pifer, P. M., Zheng, L., Gottlieb, E., Denvir, J., & Frisch, S. M. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0050 · Cited by 43
Yang, B., Li, G., Wang, S., Zheng, Y., Zhang, J., Pan, B., Wang, N., & Wang, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07123-5 · Cited by 40
Tumor-produced ammonia is metabolized by regulatory T cells to further impede anti-tumor immunity
Gu, J., Yu, L., Chen, Q., Song, Z., Qian, Q., Liang, Y., Huang, T., Qiao, L., Li, X., Yu, M., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.034 · Cited by 47
Hu, M., Liu, L., & Yao, W. (2018) · Gene · doi:10.1016/j.gene.2018.08.048 · Cited by 39
Wang, L., Zhu, L., Wu, K., Chen, Y., Lee, D., Guček, M., & Sack, M. N. (2019) · Hepatology · doi:10.1002/hep.30876 · Cited by 38
Violacein induces death of RAS-mutated metastatic melanoma by impairing autophagy process
Gonçalves, P. R., Pelizzaro‐Rocha, K. J., Fernandes, M. R. N., Abrantes, J. L. F., Durán, N., & Ferreira‐Halder, C. V. (2016) · Tumor Biology · doi:10.1007/s13277-016-5265-x · Cited by 38
Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer
Yu, Y. W., Yu, X., Fan, C., Wang, H., Wang, R., Feng, C., & Guan, H. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1659-0 · Cited by 38
Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism
Nguyen, T.-L., & Durán, R. V. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.026 · Cited by 40
Self-citationTian, Y., Jiang, W., Wang, W., Mao, G., Li, Y., & Li, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120736 · Cited by 36
The Arabidopsis Target of Rapamycin kinase regulates ammonium assimilation and glutamine metabolism
Ingargiola, C., Jéhanno, I., Forzani, C., Marmagne, A., Broutin, J., Clément, G., Leprince, A., & Meyer, C. (2023) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiad216 · Cited by 35
Extracellular Vesicle-Mediated Mitochondrial Reprogramming in Cancer
Carles-Fontana, R., Heaton, N. D., Palma, E., & Khorsandi, S. E. (2022) · Cancers · doi:10.3390/cancers14081865 · Cited by 37
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
Duraj, T., Carrión-Navarro, J., Seyfried, T. N., Garcia‐Romero, N., & Ayuso‐Sacido, Á. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101389 · Cited by 36
Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI Almonertinib
Liu, Y., Ge, X., Pang, J., Zhang, Y., Zhang, H., Wu, H., Fan, F., & Liu, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671328 · Cited by 31
Unfolding the role of autophagy in the cancer metabolism
Pandey, A., Yadav, P., & Shukla, S. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101158 · Cited by 31
Lin, F., Gao, L., Su, Z., Cao, X., Zhan, Y., Li, Y., & Zhang, B. (2018) · Oncology Reports · doi:10.3892/or.2018.6451 · Cited by 28
Loss of SDHB Induces a Metabolic Switch in the hPheo1 Cell Line toward Enhanced OXPHOS
Tabebi, M., Dutta, R. K., Skoglund, C., Söderkvist, P., & Gimm, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010560 · Cited by 27
Hujber, Z., Petővári, G., Szoboszlai, N., Dankó, T., Nagy, N., Kriston, C., Krencz, I., Paku, S., Ozohanics, O., Drahos, L., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0544-y · Cited by 26
Li, Y., Qian, W., Wang, D., Meng, Y., Wang, X., Chen, Y., Li, X., Xie, C., Zhong, C., & Fu, S. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3636 · Cited by 24
Lopinavir enhances anoikis by remodeling autophagy in a circRNA-dependent manner
Wu, Y., Chen, Y., Yan, X., Dai, X., Liao, Y., Yuan, J., Wang, L., Liu, D., Niu, D., Sun, L., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2325304 · Cited by 23
Pharmacologic approaches to amino acid depletion for cancer therapy
Wilder, C. S., Chen, Z., & DiGiovanni, J. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23349 · Cited by 23
Chen, H., Wu, Q., Peng, L., Cao, T., Deng, M.-L., Liu, Y.-W., Huang, J., Hu, Y., Fu, N., Zhou, K.-B., et al. (2021) · Journal of Nanomaterials · doi:10.1155/2021/5164100 · Cited by 22
Cao, S., Hung, Y., Wang, Y.-C., Chung, Y., Qi, Y., Ouyang, C., Zhong, X., Hu, W., Coblentz, A., Maghami, E. G., et al. (2022) · Theranostics · doi:10.7150/thno.73896 · Cited by 25
One-Carbon and Polyamine Metabolism as Cancer Therapy Targets
Islam, A., Shaukat, Z., Hussain, R., & Gregory, S. L. (2022) · Biomolecules · doi:10.3390/biom12121902 · Cited by 22
Wang, X., Xiao-xia, Y., Peng-Fei, S., Zong-Xue, Z., & Xiu-li, G. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175323 · Cited by 23
Zhang, J., Chen, M., Yang, Y., Liu, Z., Guo, W., Xiang, P., Zeng, Z., Wang, D., & Xiong, W. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31349 · Cited by 23
Nguyen, T.-L., Nokin, M., Egorov, M., Tomé, M., Bodineau, C., Primo, C. D., Minder, L., Wdzieczak‐Bakala, J., Garcia-Alvarez, M. C., Bignon, J. S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0232 · Cited by 24
Self-citationMetabolic reprogramming and its clinical application in thyroid cancer (Review)
Wen, S., Zhang, T., Xue, D.-X., Wu, W.-L., Wang, Y., Wang, Y., Ji, Q., Zhu, Y., Qu, N., & Shi, R. (2019) · Oncology Letters · doi:10.3892/ol.2019.10485 · Cited by 21
Ubiquitylation of the ER-Shaping Protein Lunapark via the CRL3KLHL12 Ubiquitin Ligase Complex
Yuniati, L., Lauriola, A., Gerritsen, M., Abreu, S., Ni, E., Tesoriero, C., Onireti, J., Low, T. Y., Heck, A. J. R., Vettori, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107664 · Cited by 20
Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment
Yang, H., Li, J., Niu, Y., Zhou, T., Zhang, P., Liu, Y., & Li, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1494788 · Cited by 23
Mitochondria as Regulators of Nonapoptotic Cell Death in Cancer
Malla, S., Neupane, R., Sood, S., Hussein, N. A., Abou-Dahech, M. S., Terrero, D., Ashby, C. R., Babu, R. J., & Tiwari, A. K. (2025) · MedComm · doi:10.1002/mco2.70244 · Cited by 20
Wu, C., Cai, X., Yan, J., Deng, A., Cao, Y., & Zhu, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.589663 · Cited by 18
Ferroptosis, Acyl Starvation, and Breast Cancer
Bobiński, R., Dutka, M., Pizon, M., Waksmańska, W., & Pielesz, A. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.122.000607 · Cited by 20
Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance
Zarzuela, L., Durán, R. V., & Tomé, M. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13571 · Cited by 19
Self-citationDhas, N. L., Kudarha, R. R., Tıwarı, R., Tiwari, G., Garg, N., Kumar, P., Kulkarni, S., Kulkarni, J., Soman, S., Hegde, A. R., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122629 · Cited by 20
Cao, Y., Lu, C., Beeraka, N. M., Efetov, S. K., Enikeev, M. E., Fu, Y., Yang, X., Basappa, B., He, M., & Li, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1428920 · Cited by 20
Liu, W., Pan, P.-Y., Sun, Y., Wang, J., Zhou, H., Xie, X., Duan, Z., Dong, H.-Y., Chen, W., Zhang, L.-D., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.794735 · Cited by 19
Amino acids metabolism: a potential target for cancer treatment
Ren, S., Zhou, X., Wang, Z., & Yuan, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02523-3 · Cited by 19
Chen, J., Gao, P., Peng, L., Liu, T., Wu, F., Xu, K., Chen, L., Tan, F., Xing, P., Wang, Z., et al. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23403 · Cited by 16
Duan, L., Perez, R. E., & Maki, C. G. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1523858 · Cited by 15
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
Villar, V. H., Nguyen, T.-L., Terés, S., Bodineau, C., & Durán, R. V. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1297284 · Cited by 14
Self-citationMiki, K., Yagi, M., Hatae, R., Otsuji, R., Miyazaki, T., Katsuhiro, G. O. T. O., Setoyama, D., Fujioka, Y., Sangatsuda, Y., Kuga, D., et al. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00364-0 · Cited by 13
Wu, Z., Wen, Z., Li, Z., Yu, M., & Ye, G. (2021) · Medicine · doi:10.1097/md.0000000000023836 · Cited by 13
Mitochondria, Autophagy and Inflammation: Interconnected in Aging
Silva, R. C. M. C. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01231-x · Cited by 13
Profir, M., Roşu, O., Creţoiu, S. M., & Gașpar, B. S. (2024) · Microorganisms · doi:10.3390/microorganisms12050955 · Cited by 12
Duan, G., Song, Z., Qi, M., Bai, X., Wang, J., Zhang, Y., Zou, X., Guo, Q., & Wan, P. (2018) · BioMed Research International · doi:10.1155/2018/1736738 · Cited by 12
Burgeoning Strategies for Cancer Therapy Based on Ferroptosis Induced by Nanomaterials
Gao, F., Liu, H., Liu, J., & Chen, C. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202511199 · Cited by 11
Sun, R., Xu, Y., Zhang, H., Yang, Q., Wang, K., Shi, Y., & Wang, Z. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.595242 · Cited by 11
Moreira, J. D. V., Staercke, L. D., Martínez-Basilio, P. C., Gauthier-Thibodeau, S., Montégut, L., Schwartz, L. H., & Jolicœur, M. (2021) · Metabolites · doi:10.3390/metabo11060344 · Cited by 11
Zhang, C., Ding, J., Xu, X., Liu, Y., Huang, W., Da, L., Ma, Q., & Chen, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.645024 · Cited by 11
T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity
Bordignon, C., Canu, A., Dyczko, A., Leone, S., & Monti, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0848-5 · Cited by 10
Diao, B., Fan, Z., Zhou, B., & Zhan, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151012 · Cited by 9
Regulation of dendritic cell biology by amino acids and their transporters
Chen, S.-L., Li, G., Jiang, Z., Xu, Y., Aipire, A., & Li, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1626973 · Cited by 13
Untargeted Metabolomics to Go beyond the Canonical Effect of Acetylsalicylic Acid
Minno, A. D., Porro, B., Turnu, L., Manega, C. M., Eligini, S., Barbieri, S., Chiesa, M., Poggio, P., Squellerio, I., Anesi, A., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010051 · Cited by 9
Wu, S., Ai, Y., Huang, H., Wu, G., Zhou, S., Hong, W., Akuetteh, P. D. P., Jin, G., Zhao, X., Zhang, Y., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02562-6 · Cited by 9
Mi, L., Lei, L., Yin, X., Li, N., Shi, J., Han, X., Duan, X., Zhao, M., Han, G., Wang, J., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20201313 · Cited by 8
Erratum: Urine-derived stem cells accelerate the recovery of injured mouse hepatic tissue.
Hu, C., He, Y., Fang, S., Tian, N., Gong, M., Xu, X., Zhao, L., Wang, Y., He, T., Zhang, Y., et al. (2020) · PubMed Central · Cited by 7
A control theoretic three timescale model for analyzing energy management in mammalian cancer cells
Dasgupta, A., Bakshi, A., Chowdhury, N., & De, R. K. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.019 · Cited by 7
Fang, S., Cui, J., Gong, M., He, Y., Zhang, J., & Bi, Y. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.05.04 · Cited by 5
Wu, M., Chen, G., Li, X., Ma, W., Chen, Y., Gong, Y., Zheng, H., Gu, G., Ding, Y., Dong, P., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111622 · Cited by 4
Amino Acids Supplementation in Cancer: What Do We Feed, the Patient or the Tumor?
Corsetti, G., Pasini, E., Romano, C., & Dioguardi, F. S. (2025) · Nutrients · doi:10.3390/nu17172813 · Cited by 4
Zhang, Y., Liu, H., Liu, X., & Lang, L. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436183.78 · Cited by 4
Metadata
- Authors
- Villar, V. H., Merhi, F., Djavaheri-Mergny, M., & Durán, R. V.
- Affiliations
- Université de Bordeaux (FR)
- INSERM U916 VINCO; Institut Bergonié; Bordeaux, France
- Corresponding author
- Durán, Raúl V
- Venue
- Autophagy
- Publisher
- Informa UK Limited
- Published
- 2015-08-03
- Volume
- 11
- Issue
- 8
- Pages
- 1198-1208
- ISSN
- 1554-8627 (ISSN-L)
- 1554-8635
- PMC
- PMC4590661
- OpenAlex
- W1768966319
- Cited by
- 143
- References
- 145
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 14 · 2023: 9 · 2022: 18 · 2021: 18 · 2020: 18 · 2019: 12 · 2018: 15 · 2017: 12 · 2016: 5 · 2015: 1
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Autophagy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Fondation ARC pour la Recherche sur le Cancer
- Ligue Contre le Cancer
- Institut National Du Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- glutaminolysis, cancer metabolism, mTORC1 signaling, cancer cell energy metabolism, targeted cancer therapy, treatment resistance, tumor recurrence, tumor progression
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Autophagy, Cell Transformation, Neoplastic, Glutamine, Humans, Ketoglutaric Acids, Neoplasm Recurrence, Local, Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Drug Resistance, Neoplasm, Multiprotein Complexes, Cell Proliferation, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review